A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
01/1994
01/04/1994	CA1325776C Transparent antiperspirant stick compositions
01/03/1994	CA2099441A1 Non-irritating dentifrice
12/1993
12/29/1993	EP0575844A2 Hydroxamic acid derivatives and pharmaceutical compositions thereof
12/29/1993	EP0575482A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
12/28/1993	US5273747 Commiphora mukul extracts and therapeutical applications thereof
12/28/1993	US5273550 Using 5,6-dihydroxyindole obtained from the oxidation of dopa to diffuse into the hair and generate a hair coloring amount of melanin
12/28/1993	CA1325599C Cosmetic composition
12/28/1993	CA1325596C Non-aqueous topical composition containing an ester of pyroglutamic acid
12/26/1993	CA2098166A1 Hydroxamic acid derivatives
12/23/1993	WO1993025669A1 Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
12/23/1993	WO1993025217A1 Des-tyr dynorphin analogues
12/23/1993	WO1993025183A1 Mouthwash for treating dentine hypersensitivity
12/23/1993	DE4243287A1 N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use
12/23/1993	CA2138139A1 Mouthwash for treating dentine hypersensitivity
12/23/1993	CA2137916A1 Des-tyr dynorphin analogues
12/22/1993	EP0574758A1 Hydroxamic acid derivatives as collagenase inhibitors
12/22/1993	EP0574457A1 Antiviral nucleoside combination
12/22/1993	EP0574404A1 Psyllium and cholestyramine compositions with improved palatability
12/22/1993	EP0315682B1 Avirulent microbes and uses therefor
12/21/1993	US5272064 DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
12/15/1993	EP0573584A1 Method of treating pulmonary inflammation
12/14/1993	US5270320 Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases
12/14/1993	CA1325209C Certain 2-substituted adenosine derivatives
12/12/1993	CA2098168A1 Hydroxamic acid derivatives
12/09/1993	WO1993024521A1 Bpc peptides, their preparation and use
12/09/1993	WO1993024148A1 Combined vaccines comprising hepatitis b surface antigen and other antigens
12/09/1993	WO1993024142A1 New pharmaceutical uses of krill enzymes
12/09/1993	WO1993024105A1 Topical antiperspirant composition consisting essentially of non-toxic water-insoluble occlusive film-forming antiperspirant polymer
12/09/1993	WO1993024002A1 1-[n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylene derivatives for use against fleas on pets
12/09/1993	CA2306952A1 Method for removing dental plaque
12/09/1993	CA2136413A1 Topical antiperspirant composition consisting essentially of non-toxic water in-soluble occlusive film-forming antiperspirant polymer
12/08/1993	EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy
12/08/1993	EP0572542A1 Method of treating systemic lupus erythematosus
12/08/1993	EP0538443A4 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
12/08/1993	CN1079147A Urapidil slow-release preparation
12/01/1993	EP0571593A1 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them.
12/01/1993	CN1078884A Stabilized solid pharmaceutical preparation and method of producing the same
11/1993
11/30/1993	US5266564 Method for treating certain autoimmune diseases
11/30/1993	US5266331 Controlled release oxycodone compositions
11/30/1993	CA1324759C Topical composition containing an ester of pyroglutamic acid
11/25/1993	WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/24/1993	EP0571086A1 Hair care composition
11/24/1993	EP0570838A1 S-triazine derivatives as light stabilisers
11/24/1993	EP0420862B1 Pharmaceutical composition containing deoxyribonucleosides for wound healing
11/23/1993	CA1324577C Cosmetic product
11/18/1993	EP0570085A2 Antiperspirant aerosol composition with high solids content
11/17/1993	CN1078388A Treatment of disease employing hyuluronic acid and NSAIDS
11/16/1993	CA1324318C Method and solution for eliminating intra-abdominal infections
11/11/1993	WO1993021907A1 Pharmaceutical preparation and process for its manufacture
11/09/1993	US5260447 Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use
11/09/1993	US5260054 Cysteamine permanent wave composition and method
11/09/1993	CA2095499A1 Depot preparation
11/09/1993	CA1324137C Process for the preparation of quinoline carboxylic acids
11/09/1993	CA1324129C Prostaglandins of the f series
11/03/1993	EP0514491B1 Light-resistant filtering cosmetic composition containing a uv-a filter and an alkyl beta, beta-diphenylacrylate or an alkyl alpha-cyano-beta, beta-diphenylacrylate
11/03/1993	EP0500793B1 Osmotic, oral dosage form for fertility control
11/02/1993	US5258183 Medicine based on neutralized sulphur derivatives
11/02/1993	US5258174 Reaction product of a metal salt, a complexing agent, a hardening agent and a solvent
10/1993
10/28/1993	WO1993020832A1 Rectal pharmaceutical compositions for the treatment of prostatic hypertrophy
10/28/1993	WO1993020808A1 Aminoguanidine spray drying process
10/28/1993	CA2118324A1 Substituted indolizino¬1,2-b\|quinolinones
10/27/1993	EP0567311A2 Hydrocolloid wound gel
10/27/1993	EP0567271A2 Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
10/27/1993	EP0567201A2 Vehicles for oral administration of a specific pharmaceutically active acid labile substance
10/27/1993	EP0566647A1 Improved humanized immunoglobulins
10/27/1993	EP0566566A1 Compositions and methods for alleviating menopausal symptoms.
10/27/1993	EP0523109A4 Hair styling shampoos
10/27/1993	CN1077588A Pesticides, insecticides, miticides and nematocides compositions containing new silanes derivatives
10/27/1993	CN1022564C Anti high cholesterol blood tetrazole compound intermediate product and its preparing method
10/26/1993	US5256402 Aqueous mixture of calcium pyrophosphate, urea peroxide, alkali metal pyrophosphate
10/20/1993	EP0566340A1 Cosmetic composition
10/20/1993	EP0566066A1 Antigens of human non-small lung carcinoma
10/20/1993	EP0566049A1 Conditioning shampoo composition and method of preparing and using the same
10/19/1993	US5254336 Method of increasing hair shine and repairing alkaline-damaged hair
10/18/1993	CA2094219A1 Stabilized solid pharmaceutical preparation and method of producing the same
10/17/1993	CA2093781A1 Antiperspirant aerosol composition with high solids content
10/14/1993	WO1993020052A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
10/14/1993	WO1993019762A1 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv)
10/14/1993	CA2093627A1 Cosmetic composition
10/13/1993	EP0565412A1 Compositions containing 5-iodouracil derivatives for the treatment of hepatitis B infections
10/13/1993	EP0565401A1 Continuous process for making a non-newtonian paste or cream like material
10/13/1993	EP0565208A1 DNA fragment encoding OspA of Borrelia burgdorferi, vaccine and diagnostics comprising OspA encoded by the DNA fragment
10/13/1993	EP0414700B1 Contrast agents for magnetic resonance imaging
10/12/1993	CA1322961C Oral composition
10/07/1993	CA2092356A1 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv)
10/06/1993	EP0564277A1 Moisturing cosmetic compositions
10/06/1993	EP0563060A1 Synergism of tnf and il-4
10/06/1993	CN1022324C Anhydrous crystal sodium salt of 5-chloro-3-(2-thenoyl)-2-oxyindole-1-carboxamide
09/1993
09/30/1993	WO1993018777A1 Use of mannose phosphates for the treatment of fibrotic disorders
09/30/1993	WO1993018776A1 Combinations of compounds having antiviral activity
09/30/1993	WO1993018752A1 Topical and transdermal delivery system utilizing submicron oil spheres
09/30/1993	WO1993018746A1 Pressurized gas packagings using polyoxyethylene glyceryl-obates
09/30/1993	CA2590810A1 Topical and transdermal delivery system utilizing submicron oil spheres
09/29/1993	EP0562637A1 Opacifier for water-based compositions
09/29/1993	CN1076690A Sulfonamidocarboxamides
09/29/1993	CN1022243C Method of preparation of indole derivatives
09/23/1993	DE4230876A1 Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten Aerosols under-use of polyoxyethylene glyceryl oleates
09/22/1993	EP0560967A1 Use of aica riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow
09/22/1993	EP0474712B1 Lysolecithin derivatives for treating autoimmune diseases
09/21/1993	US5247076 Imidazolidyl macrolides having immunosuppressive activity

1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 295